Further, lymphocyte cytosolic protein 1 shuttled by BMSC-derived exosomes has been reported to promote cell proliferation and metastasis in osteosarcoma (10), while BMSC-derived exosomal miR-206 has been highlighted to impede osteosarcoma progression (11), indicating the promising role of EVs derived from BMSCs in the management of osteosarcoma. This evidence concerns the gene LCP1 and osteosarcoma.